These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 20406943)

  • 1. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study.
    Zsíros J; Maibach R; Shafford E; Brugieres L; Brock P; Czauderna P; Roebuck D; Childs M; Zimmermann A; Laithier V; Otte JB; de Camargo B; MacKinlay G; Scopinaro M; Aronson D; Plaschkes J; Perilongo G
    J Clin Oncol; 2010 May; 28(15):2584-90. PubMed ID: 20406943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B; Bode U; von Schweinitz D
    Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group.
    Schnater JM; Aronson DC; Plaschkes J; Perilongo G; Brown J; Otte JB; Brugieres L; Czauderna P; MacKinlay G; Vos A
    Cancer; 2002 Feb; 94(4):1111-20. PubMed ID: 11920482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cure of multifocal panhepatic hepatoblastoma: is liver transplantation always necessary?
    Baertschiger RM; Ozsahin H; Rougemont AL; Anooshiravani M; Rubbia-Brandt L; Le Coultre C; Majno P; Wildhaber BE; Mentha G; Chardot C
    J Pediatr Surg; 2010 May; 45(5):1030-6. PubMed ID: 20438949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: a report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94.
    Fuchs J; Bode U; von Schweinitz D; Weinel P; Erttmann R; Harms D; Mildenberger H
    Klin Padiatr; 1999; 211(4):305-9. PubMed ID: 10472567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
    Browne M; Sher D; Grant D; Deluca E; Alonso E; Whitington PF; Superina RA
    J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing treatment and outcome of children with hepatoblastoma: analysis of a single center experience over the last 20 years.
    Ismail H; Broniszczak D; Kaliciński P; Dembowska-Bagińska B; Perek D; Teisseyre J; Kluge P; Kościesza A; Lembas A; Markiewicz M
    J Pediatr Surg; 2012 Jul; 47(7):1331-9. PubMed ID: 22813792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Features predicting unresectability in hepatoblastoma.
    D'Antiga L; Vallortigara F; Cillo U; Talenti E; Rugge M; Zancan L; Dall'Igna P; De Salvo GL; Perilongo G
    Cancer; 2007 Sep; 110(5):1050-8. PubMed ID: 17661341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma.
    Perilongo G; Maibach R; Shafford E; Brugieres L; Brock P; Morland B; de Camargo B; Zsiros J; Roebuck D; Zimmermann A; Aronson D; Childs M; Widing E; Laithier V; Plaschkes J; Pritchard J; Scopinaro M; MacKinlay G; Czauderna P
    N Engl J Med; 2009 Oct; 361(17):1662-70. PubMed ID: 19846851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.
    Fuchs J; Rydzynski J; Von Schweinitz D; Bode U; Hecker H; Weinel P; Bürger D; Harms D; Erttmann R; Oldhafer K; Mildenberger H;
    Cancer; 2002 Jul; 95(1):172-82. PubMed ID: 12115331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroblastoma.
    Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
    Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma.
    Malogolowkin MH; Katzenstein H; Krailo MD; Chen Z; Bowman L; Reynolds M; Finegold M; Greffe B; Rowland J; Newman K; Womer RB; London WB; Castleberry RP
    J Clin Oncol; 2006 Jun; 24(18):2879-84. PubMed ID: 16782927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical resection and chemotherapy improve survival rate for patients with hepatoblastoma.
    Carceller A; Blanchard H; Champagne J; St-Vil D; Bensoussan AL
    J Pediatr Surg; 2001 May; 36(5):755-9. PubMed ID: 11329582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma--results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience.
    Weeda VB; Murawski M; McCabe AJ; Maibach R; Brugières L; Roebuck D; Fabre M; Zimmermann A; Otte JB; Sullivan M; Perilongo G; Childs M; Brock P; Zsíros J; Plaschkes J; Czauderna P; Aronson DC
    Eur J Cancer; 2013 Aug; 49(12):2698-704. PubMed ID: 23683550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult type vs. Childhood hepatocellular carcinoma--are they the same or different lesions? Biology, natural history, prognosis, and treatment.
    Czauderna P
    Med Pediatr Oncol; 2002 Nov; 39(5):519-23. PubMed ID: 12228910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial liver transplantation for unresectable hepatoblastoma after chemotherapy.
    Héry G; Franchi-Abella S; Habes D; Brugières L; Martelli H; Fabre M; Pariente D; Gauthier F; Jacquemin E; Branchereau S
    Pediatr Blood Cancer; 2011 Dec; 57(7):1270-5. PubMed ID: 21910210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative transcatheter selective arterial chemoembolization in treatment of unresectable hepatoblastoma in infants and children.
    Li JP; Chu JP; Yang JY; Chen W; Wang Y; Huang YH
    Cardiovasc Intervent Radiol; 2008; 31(6):1117-23. PubMed ID: 18560935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboplatin-epirubicin regimen for the treatment of hepatoblastoma.
    Blouin P; Brugières L; Tabone MD; Leverger G; Rubie H; Branchereau S; De Kraker J
    Pediatr Blood Cancer; 2004 Feb; 42(2):149-54. PubMed ID: 14752879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrolamellar hepatocellular carcinoma in children and adolescents.
    Katzenstein HM; Krailo MD; Malogolowkin MH; Ortega JA; Qu W; Douglass EC; Feusner JH; Reynolds M; Quinn JJ; Newman K; Finegold MJ; Haas JE; Sensel MG; Castleberry RP; Bowman LC
    Cancer; 2003 Apr; 97(8):2006-12. PubMed ID: 12673731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of treatment outcome for children with recurrent or metastatic hepatoblastoma.
    Matsunaga T; Sasaki F; Ohira M; Hashizume K; Hayashi A; Hayashi Y; Mugishima H; Ohnuma N;
    Pediatr Surg Int; 2003 May; 19(3):142-6. PubMed ID: 12768314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.